CLINICAL_TRIALS
trial_result
· 2021-12-13
Clinical Trial Update: A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease [Phase 3]
Summary
Phase 3 trial of gantenerumab in prodromal Alzheimer's disease completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-12-13